Article thumbnail

Network of oral antidiabetic drugs comparison of all-cause mortality for the network meta-analysis.

By Gyeongsil Lee (4047361), Seung-Won Oh (4047355), Seung-Sik Hwang (4047358), Ji Won Yoon (172800), Sungchan Kang (4047367), Hee-Kyung Joh (2185693), Hyuktae Kwon (792156), Jeehyun Kim (1914157) and Danbee Park (4047364)

Abstract

<p>Each circle node represents a drug included in the analysis and the size of circle is proportional to the number of patients randomly assigned to the drug. Each line corresponds to direct comparison between drugs and the width of line is proportional to the number of trials comparing each pair of treatments. TZD: thiazolidinedione. DPP4: dipeptidyl peptidase-4. SGLT2: sodium glucose cotransporter-2.</p

Topics: Physiology, Pharmacology, Biotechnology, Developmental Biology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, OAD, TZD, SGLT 2 inhibitor use, Bayesian network meta-analyses, SGLT 2 inhibitors, network meta-analysis, ClinicalTrials.gov registry databases, type 2 diabetes, MI, DPP 4 inhibitor, ACS, antidiabetic drug use, antidiabetic drugs, sodium-glucose co-transporter -2, cardiovascular-related mortality, placebo, all-cause mortality
Year: 2017
DOI identifier: 10.1371/journal.pone.0177646.g002
OAI identifier: oai:figshare.com:article/5040904
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://figshare.com/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.